Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury model
Spinal cord injury (SCI) is one of the most severe central nervous system injuries. Currently, transplanting bone marrow mesenchymal stem cells (BMSCs) is considered a therapeutic option for SCI. Tanshinone II...
Source: Journal of Translational Medicine - Category: Research Authors: Xue-Mei Zhang, Jiao Ma, Yang Sun, Bing-Qian Yu, Zhuo-Min Jiao, Duo Wang, Mei-Yu Yu, Jin-Yue Li and Jin Fu Tags: Research Source Type: research
More News: Brain | Neurology | Research | Spinal Cord Injury | Stem Cell Therapy | Stem Cells | Transplants